Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥39.4bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥94.0bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥51.4bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income¥203m2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥19.6bn2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥607m2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥21.3bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥19.8bn2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥1.4bn2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥19.2bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥992m2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥13.9bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥14.3bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥992m2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥14.3bn2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥177.3bnat 2025-09-30Cons.Assets
Total assets¥190.4bnat 2025-03-31Cons.Assets
Total assets¥187.1bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥29.5bnat 2025-09-30Cons.Liabilities
Total liabilities¥37.8bnat 2025-03-31Cons.Liabilities
Net assets / equity¥147.8bnat 2025-09-30Cons.Net assets
Net assets / equity¥152.6bnat 2025-03-31Cons.Net assets
Net assets / equity¥154.4bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥45.1bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥54.1bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥57.1bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥70.1bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥84.0bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥65.3bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow−¥8.1bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥29.8bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥23.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥429m2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥19.6bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥2.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥5.2bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.4bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥2.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥26.162025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥365.422024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥377.232024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio83.4%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio80.2%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio82.5%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
Medicinereportable segmentrevenue2025-04-01 → 2025-09-30¥38.1bn
Medicinereportable segmentrevenue external2025-04-01 → 2025-09-30¥38.1bn
Medicinereportable segmentsegment profit2025-04-01 → 2025-09-30−¥479m
Real Estatereportable segmentrevenue2025-04-01 → 2025-09-30¥1.3bn
Real Estatereportable segmentrevenue external2025-04-01 → 2025-09-30¥1.3bn
Real Estatereportable segmentsegment profit2025-04-01 → 2025-09-30¥682m
Total Of Reportable Segments And Otherssegment totalrevenue2025-04-01 → 2025-09-30¥39.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-04-01 → 2025-09-30¥39.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2025-04-01 → 2025-09-30¥203m
Medicinereportable segmentrevenue2024-04-01 → 2024-09-30¥50.1bn
Medicinereportable segmentrevenue external2024-04-01 → 2024-09-30¥50.1bn
Medicinereportable segmentsegment profit2024-04-01 → 2024-09-30¥18.9bn
Real Estatereportable segmentrevenue2024-04-01 → 2024-09-30¥1.2bn
Real Estatereportable segmentrevenue external2024-04-01 → 2024-09-30¥1.2bn
Real Estatereportable segmentsegment profit2024-04-01 → 2024-09-30¥676m
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥51.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥51.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥19.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 500
ItemContextValueUnit
Dividends income noiPrior1InterimDuration288000000JPY
Dividends income noiInterimDuration320000000JPY
Foreign exchange gains noiPrior1InterimDuration-JPY
Foreign exchange gains noiInterimDuration14000000JPY
Other noiPrior1InterimDuration37000000JPY
Other noiInterimDuration19000000JPY
Non operating incomePrior1InterimDuration341000000JPY
Non operating incomeInterimDuration471000000JPY
Interest expenses noePrior1InterimDuration12000000JPY
Interest expenses noeInterimDuration21000000JPY
Foreign exchange losses noePrior1InterimDuration54000000JPY
Foreign exchange losses noeInterimDuration-JPY
Loss on investments in partnership noePrior1InterimDuration16000000JPY
Loss on investments in partnership noeInterimDuration38000000JPY
Other noePrior1InterimDuration15000000JPY
Other noeInterimDuration7000000JPY
Non operating expensesPrior1InterimDuration97000000JPY
Non operating expensesInterimDuration67000000JPY
Ordinary incomePrior1InterimDuration19823000000JPY
Ordinary incomeInterimDuration607000000JPY
Gain on sales of investment securities eiPrior1InterimDuration-JPY
Gain on sales of investment securities eiInterimDuration862000000JPY
Other eiPrior1InterimDuration0JPY
Other eiInterimDuration1000000JPY
Extraordinary incomePrior1InterimDuration0JPY
Extraordinary incomeInterimDuration863000000JPY
Loss on retirement of noncurrent assets elPrior1InterimDuration41000000JPY
Loss on retirement of noncurrent assets elInterimDuration64000000JPY
Loss on valuation of investment securities elPrior1InterimDuration546000000JPY
Loss on valuation of investment securities elInterimDuration2000000JPY
Other elPrior1InterimDuration0JPY
Other elInterimDuration6000000JPY
Extraordinary lossPrior1InterimDuration588000000JPY
Extraordinary lossInterimDuration73000000JPY
Income before income taxesPrior1InterimDuration19235000000JPY
Income before income taxesInterimDuration1397000000JPY
Income taxesPrior1InterimDuration4949000000JPY
Income taxesInterimDuration404000000JPY
Profit lossPrior1InterimDuration14286000000JPY
Profit lossInterimDuration992000000JPY
Profit loss attributable to owners of parentPrior1InterimDuration14286000000JPY
Profit loss attributable to owners of parentInterimDuration992000000JPY
Profit lossPrior1InterimDuration14286000000JPY
Profit lossInterimDuration992000000JPY
Valuation difference on available for sale securities net of tax ociPrior1InterimDuration-775000000JPY
Valuation difference on available for sale securities net of tax ociInterimDuration12000000JPY
Foreign currency translation adjustment net of tax ociPrior1InterimDuration-JPY
Foreign currency translation adjustment net of tax ociInterimDuration-557000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1InterimDuration-40000000JPY
Remeasurements of defined benefit plans net of tax ociInterimDuration-68000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass rounding
balance sheet identityconsolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass